De Laet, Anna
Piccardi, Elena Serena
Begum-Ali, Jannath
Charman, Tony
Johnson, Mark H.
Jones, Emily J. H.
Bedford, Rachael
Gliga, Teodora
,
Agyapong, Mary
Bazelmans, Tessel
Dafner, Leila
Ersoy, Mutluhan
Goodwin, Amy
Haartsen, Rianne
Halkola, Hanna
Hendry, Alexandra
Holman, Rebecca
Kalwarowsky, Sarah
Kolesnik-Taylor, Anna
Lloyd-Fox, Sarah
Mason, Luke
Narvekar, Nisha
Pasco, Greg
Pirazzoli, Laura
Taylor, Chloƫ
Funding for this research was provided by:
Wellcome Trust (204770/Z/16/Z, 217469/Z/19/Z)
Medical Research Council (MR/K021389/1, MR/K021389/1)
Innovative Medicines Initiative (115300, 115300, 777394)
King's College London (204823/Z/16/Z)
Article History
Received: 13 January 2022
Accepted: 4 May 2022
First Online: 19 August 2022
Competing interests
: Professor Tony Charman has received consultancy fees from Servier Laboratories and royalties from Sage Publications and Guilford Publications. All other authors declare no conflict of interest.